Epidermolysis bullosa pruriginosa masquerading as psychogenic pruritus

Archives of Dermatology

Volumn 147, Issue 8, 2011, Pages 956-960

  Tey, Hong Liang ^a   Lee, Andrew D ^b   Almaani, Noor ^b   McGrath, John A ^b   Mills, Kyle C ^a   Yosipovitch, Gil ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; COLLAGEN TYPE 4; CORTICOSTEROID; CYCLOSPORIN; TACROLIMUS;

ADOLESCENT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CASE REPORT; COLLAGEN TYPE 4 GENE; DIAGNOSTIC ERROR; DRUG RESPONSE; EPIDERMOLYSIS BULLOSA; EPIDERMOLYSIS BULLOSA PRURIGINOSA; FAMILY; GENE; GENE MUTATION; HETEROZYGOTE; HUMAN; HUMAN TISSUE; LOW DRUG DOSE; MALE; NAIL DYSTROPHY; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; PRURITUS; PSYCHOGENIC PRURITUS;

ADOLESCENT; DIAGNOSIS, DIFFERENTIAL; EPIDERMOLYSIS BULLOSA DYSTROPHICA; HUMANS; MALE; PRURITUS;

EID: 80051685129     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2011.189     Document Type: Article

References (29)

1. McGrath JA, Schofield OM, Eady RA. Epidermolysis bullosa pruriginosa: dystrophic epidermolysis bullosa with distinctive clinicopathological features. Br J Dermatol. 1994;130(5):617-625. (Pubitemid 24204699)
2. Cambiaghi S, Brusasco A, Restano L, Cavalli R, Tadini G. Epidermolysis bullosa pruriginosa. Dermatology. 1997;195(1):65-68. (Pubitemid 27326716)
3. Saito M, Masunaga T, Ishiko A. A novel de novo splice-site mutation in the COL7A1 gene in dominant dystrophic epidermolysis bullosa (DDEB): specific exon skipping could be a prognostic factor for DDEB pruriginosa. Clin Exp Dermatol. 2009; 34(8):e934-e936. doi:10.1111/j.1365-2230.2009.03254.x.
4. Lee JY, Pulkkinen L, Liu HS, Chen YF, Uitto J. A glycine-to-arginine substitution in the triple-helical domain of type VII collagen in a family with dominant dystrophic epidermolysis bullosa pruriginosa. J Invest Dermatol. 1997;108(6):947-949. (Pubitemid 27272416)
5. Mellerio JE, Ashton GH, Mohammedi R, et al. Allelic heterogeneity of dominant and recessive COL7A1 mutations underlying epidermolysis bullosa pruriginosa. J Invest Dermatol. 1999;112(6):984-987. (Pubitemid 29278003)
6. Whittock NV, Ashton GH, Mohammedi R, et al. Comparative mutation detection screening of the type VII collagen gene (COL7A1) using the protein truncation test, fluorescent chemical cleavage ofmismatch, and conformation sensitive gel electrophoresis. J Invest Dermatol. 1999;113(4):673-686. (Pubitemid 29489634)
7. Murata T, Masunaga T, Shimizu H, et al. Glycine substitution mutations by different amino acids in the same codon of COL7A1 lead to heterogeneous clinical phenotypes of dominant dystrophic epidermolysis bullosa. Arch Dermatol Res. 2000;292(10):477-481. (Pubitemid 32112804)
8. Jiang W, Bu D, Yang Y, Zhu X. A novel splice site mutation in collagen type VII gene in a Chinese family with dominant dystrophic epidermolysis bullosa pruriginosa. Acta Derm Venereol. 2002;82(3):187-191. (Pubitemid 34848393)
9. Nakamura H, Sawamura D, Goto M, et al. The G2028R glycine substitution mutation in COL7A1 leads to marked inter-familiar clinical heterogeneity in dominant dystrophic epidermolysis bullosa. J Dermatol Sci. 2004;34(3):195-200. (Pubitemid 38543002)
10. Chuang GS, Martinez-Mir A, Yu HS, et al. A novel missense mutation in the COL7A1 gene underlies epidermolysis bullosa pruriginosa. Clin Exp Dermatol. 2004; 29(3):304-307. (Pubitemid 38658477)
11. Drera B, Castiglia D, Zoppi N, et al. Dystrophic epidermolysis bullosa pruriginosa in Italy: clinical and molecular characterization. Clin Genet. 2006;70(4):339-347. (Pubitemid 44323401)
12. Dang N, Klingberg S, Marr P, Murrell DF. Review of collagen VII sequence variants found in Australasian patients with dystrophic epidermolysis bullosa reveals nine novel COL7A1 variants. J Dermatol Sci. 2007;46(3):169-178. (Pubitemid 46601841)
13. Ee HL, Liu L, Goh CL, McGrath JA. Clinical and molecular dilemmas in the diagnosis of familial epidermolysis bullosa pruriginosa. J Am Acad Dermatol. 2007; 56(5)(suppl):S77-S81. (Pubitemid 46566525)
14. Almaani N, Liu L, Harrison N, et al. New glycine substitution mutations in type VII collagen underlying epidermolysis bullosa pruriginosa but the phenotype is not explained by a common polymorphism in the matrix metalloproteinase-1 gene promoter. Acta Derm Venereol. 2009;89(1):6-11.
15. Schumann H, Has C, Kohlhase J, Bruckner-Tuderman L. Dystrophic epidermolysis bullosa pruriginosa is not associated with frequent FLG gene mutations. Br J Dermatol. 2008;159(2):464-469. (Pubitemid 352009874)
16. Wang Y, Zhao J, Tu P, Jiang W, Zhu X. A novel missense mutation in COL7A1 in a Chinese pedigree with epidermolysis bullosa pruriginosa. J Dermatol Sci. 2007; 46(3):211-213. (Pubitemid 46601836)
17. Shi BJ, Feng J. A novel missense mutation in the COL7A1 gene causes epidermolysis bullosa pruriginosa. Clin Exp Dermatol. 2009;34(8):e975-e978.
18. Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med. 2011;17(1-2):113-125.
19. Materazzi S, Pellerito S, Di Serio C, et al. Analysis of protease-activated receptor-1 and -2 in human scar formation. J Pathol. 2007;212(4):440-449. (Pubitemid 47099021)
20. Steinhoff M, Neisius U, Ikoma A, et al. Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci. 2003;23(15):6176-6180. (Pubitemid 36875617)
21. Yamasaki H, Tada J, Yoshioka T, Arata J. Epidermolysis bullosa pruriginosa (McGrath) successfully controlled by oral cyclosporin. Br J Dermatol. 1997;137 (2):308-310. (Pubitemid 27333377)
22. Ozanic Bulic S, Fassihi H, Mellerio JE, McGrath JA, Atherton DJ. Thalidomide in the management of epidermolysis bullosa pruriginosa. Br J Dermatol. 2005; 152(6):1332-1334. (Pubitemid 40933439)
23. Banky JP, Sheridan AT, Storer EL, Marshman G. Successful treatment of epidermolysis bullosa pruriginosa with topical tacrolimus. Arch Dermatol. 2004; 140(7):794-796. (Pubitemid 38917846)
24. Sonkoly E, Muller A, Lauerma AI, et al. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol. 2006;117(2):411-417. (Pubitemid 43192023)
25. Tanaka A, Arita K, Lai-Cheong JE, Palisson F, Hide M, McGrath JA. New insight into mechanisms of pruritus from molecular studies on familial primary localized cutaneous amyloidosis. Br J Dermatol. 2009;161(6):1217-1224.
26. Nagy N, Tanaka A, Techanukul T, McGrath JA. Common IL-31 gene haplotype associated with non-atopic eczema is not implicated in epidermolysis bullosa pruriginosa. Acta Derm Venereol. 2010;90(6):631-632.
27. Das JK, Sengupta S, Gangopadhyay AK. Epidermolysis bullosa pruriginosa: report of three cases. Indian J Dermatol Venereol Leprol. 2005;71(2):109-111. (Pubitemid 40976326)
28. Das S, Roy AK, Kar C, Giri PP. Epidermolysis bullosa pruriginosa: a rare autosomal dominant variant. J Indian Med Assoc. 2007;105(7):388-390. (Pubitemid 351252348)
29. Almaani N, Liu L, Perez A, Robson A, Mellerio JE, McGrath JA. Epidermolysis bullosa pruriginosa in association with lichen planopilaris. Clin Exp Dermatol. 2009;34(8):e825-e828. doi:10.1111/j.1365-2230.2009.03568.x.